Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 23, 2010

View Archived Issues

Solithromycin shows potential against Plasmodium spp. and Mycobacterium leprae

HM-A42 ameliorates disease symptoms in models of asthma, RA and MS

First-in-human data presented on OMP-21M18 in solid tumors

CTAP-201 shows promise in patients with secondary hyperparathyroidism on hemodialysis

Anacetrapib is efficacious and safe in phase III DEFINE trial

Resolvyx Pharma divulges novel resolvin agents for ophthalmic disorders

Abbott discloses new agents for HCV infections

Boehringer Ingelheim and f-star collaborate to discover therapeutic antibodies

ImmunGene receives U.S. government grant for antibody-cytokine fusion technology

D-3263 HCl may stabilize disease in patients with advanced prostate cancer

Experiments illuminate mechanism of action of CXB-909

Convergence Pharma and Selcia collaborate on drug candidates for chronic pain

U.S. DoD recommends funding development of STA-9584 for prostate cancer

CIS Bio withdraws E.U. marketing authorization for NeoSpect

Omthera agrees with FDA on special protocol assessment for Epanova trial

Neurocrine Biosciences completes Daisy Petal trial of elagolix in endometriosis

Mimetogen Pharma's MIM-D3 enters phase II trial in dry eye syndrome

Ono Pharma announces highlights of first half fiscal year 2010

Basilea Pharma begins phase I trial of BAL-30072 for in-hospital infections

Bionor Pharma reverses decision to terminate development of Vacc-4x

Evotec and Merck KGaA join to develop preclinical candidates for neurological disease

FDA places Helix BioPharma's phase II/III IND application for topical interferon alfa-2b on hold

Nerviano Medical Sciences claims new HSP 90 inhibitors

New modulators discovered of metabotropic glutamate mGlu5 receptor

New Juvista formulation for children significantly improves scar appearance

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...